Analysis of the therapeutic effects of reduction ascending aortoplasty on bicuspid aortic valve with ascending aortic dilatation

Jiang ZHU,Zhuodong LI,Keng ZHONG,Mengwei TAN,Hao TANG,Zhiyun XU
DOI: https://doi.org/10.3969/j.issn.1673-6583.2017.03.012
2017-01-01
Abstract:Objective:To analyze the therapeutic effects of reduction ascending aortoplasty (RAA) on bicuspid aortic valve (BAV) with ascending aortic dilatation.Methods:Two hundred and eight patients with BAV complicating ascending aortic dilatation who underwent aortic valve replacement (AVR) and RAA in Changhai Hospital were analyzed retrospectively from Jan 2006 to Dec 2015.The patients were divided into BAV group and tricuspid aortic valve (TAV) group according to the aortic valve.In BAV group, the patients were divided into <30 mm group and ≥30 mm group according to the target diameter of ascending aorta during the operation.Results:Post-operative mortality, complication rate, reoperation rate, and diameter of ascending aorta during follow-up had no significant difference between BAV and TAV group (all P>0.05).The diameter of ascending aorta during follow-up was significantly shorter and the degree of dilatation in ascending aorta was smaller at 5 and 9 years after operation in patients whose diameter of ascending aortas <30 mm during operation than those in patients whose diameter of ascending aorta ≥30 mm (all P<0.05).Conclusion:In patients with BAV complicating ascending aortic dilatation, BAV is not an adverse factor of RAA, and the medium-long term therapeutic effect is better if the target diameter of ascending aorta is controlled under 30 mm during RAA.
What problem does this paper attempt to address?